• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Topera Medical

Abbott warns on Topera catheter spline fracture risk

May 24, 2016 By Brad Perriello

The electrophysiology business Abbott (NYSE:ABT) built around its $250 million acquisition of Topera Medical this month warned physicians about the risk that the splines on some of its Firmap catheters could fracture. Abbott EP said it received 16 reports of catheter spline fracture from October 2013 to April 18, for an incidence rate of less than 0.4%. There […]

Filed Under: Blog, Cardiovascular, Catheters, Recalls Tagged With: Abbott, Cardiac Rhythm Management, Topera Medical

Abbott, GE Healthcare ink afib deal

May 13, 2015 By Brad Perriello Leave a Comment

Abbott, GE Healthcare ink afib deal

Filed Under: News Well Tagged With: Abbott, GE Healthcare, Topera Medical

Medtech M&A: Tips from the front lines

January 22, 2015 By Amy Siegel Leave a Comment

An M&A checklist for medical device companies

S2N recently hosted an informal gathering of emerging med tech CEOs, a sort of group therapy session for people suffering from the form of temporary insanity that makes one want to be a healthcare entrepreneur.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Abbott, NeuroTherm Inc., stjudemedical, The Business of Emerging Medtech , Topera Medical

Ishrak: ‘With COV We’ll do for ORs what we’ve done for cath labs’ | The week in medtech M&A

January 14, 2015 By MassDevice Contributors Network Leave a Comment

Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'

January 12, 2015 by Brian Johnson

Filed Under: Mergers & Acquisitions, News Well Tagged With: Abbott, CardioMEMS Inc., CB Insights, Covidien, Irish High Court, Nevro Corp., Small Bone Innovations Inc., Spectranetics Corp., Topera Medical

CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014

January 7, 2015 By Brian Johnson Leave a Comment

CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014

At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.

Filed Under: Initial Public Offering (IPO), Mergers & Acquisitions, News Well Tagged With: Abbott, CardioMEMS Inc., CB Insights, Covidien, Nevro Corp., Small Bone Innovations Inc., Topera Medical, Venture Capital/Private Equity

Abbott closes $250m Topera buyout

December 23, 2014 By Brad Perriello Leave a Comment

Abbott closes $250m Topera buyout

Abbott (NYSE:ABT) said yesterday that it closed its acquisition of Topera Medical, paying $250 million up front and placing another unspecified amount on the table in performance-based milestones.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Abbott, Cardiac Rhythm Management, Topera Medical

Plan for Medtronic-Covidien management structure unveiled | The week in medtech M&A

November 5, 2014 By MassDevice Contributors Network Leave a Comment

Medtronic unveils post-merger management structure

October 30, 2014 by Val Kennedy

Filed Under: Mergers & Acquisitions, News Well Tagged With: Abbott, Biomet, Covidien, Epix Therapeutics (formerly Advanced Cardiac Therapeutics), Spectranetics Corp., Topera Medical, Zimmer Biomet

Abbott buys into electrophysiology with $250m Topera acquisition

October 29, 2014 By Brad Perriello Leave a Comment

Abbott buys into electrophysiology with $250m Topera acquisition

Filed Under: Mergers & Acquisitions, News Well Tagged With: Abbott, Electrophysiology, Epix Therapeutics (formerly Advanced Cardiac Therapeutics), Topera Medical

Topera lands FDA win for next-gen 3D Mapping System

January 6, 2014 By Chris Walker Leave a Comment

Topera lands 510(k) clearance for 3D mapping system

Topera Medical landed 510(k) clearance from the FDA for the latest incarnation of its 3D Mapping System, featuring the RhythmView workstation and FIRMap diagnostic catheter.

The imaging system uses electrical signals, captured by a multipolar electrophysiology catheter, and creates a 3D image that can more accurately map cardiac arrhythmias.

Filed Under: News Well, Regulatory/Compliance Tagged With: Cardiac Rhythm Management, Topera Medical

Topera lands CE Mark, 510(k) clearance for heart catheter

November 8, 2013 By Chris Walker Leave a Comment

Topera lands CE Mark, 510(k) clearance for heart catheter and mapping station

Topera said it landed a pair of regulatory wins for its FIRMap catheter.

The Palo Alto, Calif.-based medical device company said it won the CE Mark approval in the European Union and 510(k) clearance from the FDA for the device.

Filed Under: Catheters, Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: CE Mark, Electrophysiology, Topera Medical

Topera details $25M Series C round | Wall Street Beat

April 26, 2013 By Brad Perriello Leave a Comment

MassDevice.com Wall Street Beat

Topera said a new backer, New Enterprise Assoc., led a $25 million Series C round first reported by MassDevice.com last month, with an unnamed "strategic industry partner" joining the round.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Cardiac Rhythm Management, EndoStim, InVivo Therapeutics, Opko Health Inc., Pneuron Corp., Prolor Biotech, Sotera Wireless, Topera Medical

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy